Across TCGA pan-cancer cohorts, PPP1R1A Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PPP1R1A data layer compared with 22 for mass-spec protein and 5 for mass-spec protein.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher PPP1R1A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PPP1R1A expression acts as an unfavorable survival marker.
READ are the cancer types where PPP1R1A Mutation most reproducibly stratifies survival.